Tag Archives: gets

BMS deal quest gets a boost as Celgene swats aside another Revlimid patent challenge

Much of the investor doubt surrounding Bristol-Myers Squibb’s $ 74 billion Celgene buyout centers on the multiple myeloma blockbuster Revlimid—namely, whether its remaining patents can stand up to legal challenges. But the companies just scored a win in that department. Thursday, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) decided not… Read More »

Medicaid work requirement in Kentucky gets second approval

The Centers for Medicare and Medicaid Services has again approved a waiver for Kentucky to impose a work requirement for able-bodied Medicaid beneficiaries as a condition to receiving the benefit. CMS previously, on January 12, approved Kentucky’s request for a 1115 demonstration project waiver that included work requirements.  However, in June, a district court judge… Read More »